October 1, 1994 - September 30,1995
Armed Forces Institute of Pathology (FDA-224-82-5000). To expand the Center for Devices and Radiological Health's retrospective pathology studies of explanted medical devices and provide reimbursement for AFIP pathology.
Department of Energy (FDA-224-88-6064). To provide CDRH with access to the research fellowship program administered through Oak Ridge Associated Universities.
Environmental Protection Agency (FDA-224-88-6052). To develop animal models and strategies for risk assessment relating to developmental and reproductive toxicity of chemicals used in implantable or extracorporeal medical devices.
Georgetown University Hospital (FDA-223-92-6002). Development of a method for noninvasive detection and staging of diffuse disease processes in the liver.
Mentor Technologies, Inc. (FDA-223-94-6015). Experimental and clinical studies to evaluate the safety of clinical and cosmetic UV devices used for, or by, HIVinfected individuals.
National Academy of Sciences (FDA-223-93-6007). To establish a CDRH/FDA research associateship program through the NRC of the NAS to further the purposes of FDA in research.
National Aeronautics and Space Administration (FDA-224-77-5015). To provide a cost-effective procedure for testing and assessing medical devices intended for human use.
National Institute of Environmental Health Sciences (FDA-224-94-6013). To conduct a research program entitled "Station Support for the Regional In Vitro Magnetic Field Exposure Facility at FDA."
National Institute of Standards and Technology (FDA-224-93-6015). To provide evaluation and consulting services to the National Institute of Standards and Technology for the National Voluntary Laboratory Accreditation Program.
Office of Naval Research (FDA-224-89-6007). To determine the mechanisms by which pulsed magnetic fields affect cell function, particularly gene expression.
Office of Naval Research (FDA-224-90-6007). To study mechanisms by which pulsed magnetic fields affect protein synthesis.
Pathology Associates, Inc. (FDA-223-94-6013). A research program to evaluate mechanisms of toxicity related to materials and chemicals used in medical devices and establish markers of exposure and toxicity for potential toxicants.
SFA, Inc. (FDA-223-93-6001). To provide CDRH with data, analytical procedures, or specialized instrumentation sufficient for the generation of meaningful data that will facilitate the assessment of safety and effectiveness of medical devices and electronic products that emit radiation.
Continue to the Standards Organizations appendix.
Return to the Table of Contents.